 |
Wednesday, April 27
Risk Communication Workshop
Risk Communication Practices to Address the Quandary of Pharmaceuticals, Endocrine Disruptors, and Emerging Contaminants
Lisa Ragain, Aqua Vitae
Thursday, April 28
Federal Family of Speakers
An Approach to Pharmaceuticals and Personal Care Products in Water
John Wathen, U.S. EPA Headquarters
Best Management Practices for Unused Pharmaceuticals
Justin Pimpare, U.S. EPA Region 1
Emerging Contaminants in the Environment: An Overview of Source-to-Receptor Research by the USGS
TOXICS Program
Paul Bradley, USGS
Session 1 – Occurrence, Fate, and Transport
Pharmaceutical Manufacturing Facilities as a Source of Pharmaceuticals to Wastewater
Patrick Phillips, USGS
Preliminary Characterization of the Pharmaceutical Content of Municipal Solid Waste Landfill Leachate
Richard S. Behr, ME Department of Environmental Protection
Landfill Disposal of Unused Medicines Reduces Surface Water Releases
Douglas S. Finan, GlaxoSmithKline
Session 2 – Occurrence, Fate, and Transport
Understanding Septic Systems in Light of Pharmaceutical and Personal Care Products
Andrews Tolman, Maine CDC Drinking Water Program
Combined Sewer Outflows as a Source of Hormones to Surface Water
Patrick Phillips, USGS
Organic Wastewater Compounds in Public and Private Drinking Water Wells Impacted by Septic Systems
on Cape Cod, Massachusetts
Laurel Schaider, Silent Spring Institute
Session 3 - Aquatic & Human Health Effects
The Effects of a 30-Day In-Situ Exposure to Groundwater Bacterial Communities to Sub-Therapeutic
Concentrations of Sulfamethoxazole
Lisa Reynolds Fogarty, USGS
Antibiotic Resistance in Massachusetts Bay
Karen Lachmayr, Harvard University
Novel Fluorescence Spectroscopic Method to Quantify Trace PPCP Mixtures in Water Samples
James Killarney, University of Maine
Friday, April 29
Session 4 – Aquatic & Human Health Effects
The EPA Pilot Study of Pharmaceuticals and Personal Care Products in Fish Tissue
John B. Wathen, U.S. EPA Headquarters, Office of Water
Biological Impacts of EDCs in a Highly Effluent-Dominated River in New England
Katrina Kipp, U.S. EPA Region 1
Hermaphrodites in Your Backyard: The Landscape Ecology of Amphibian Intersex
David Skelly, Yale University
Session 5 – Removal & Treatment
Potential for Biodegradation of PPCPs in Streams
Paul Bradley, USGS
Microconstituents in Biosolids: Update on the Science
Ned Beecher, North East Biosolids and Residuals Association
Assessing Selected PPCP Removals from Various Enhanced Biofiltration Schemes
Adria Fichter, University of New Hampshire
Session 6 – Removal & Treatment
Trends in Organic Wastewater Compound Concentrations at Four New York Wastewater Treatment Plant
Effluents, 2003 – 2010
Tia-Marie Stevens, USGS
Hormones, Pharmaceutical Compounds, and Estrogenicity in New York Wastewater Effluents
Anne Ernst, USGS
Advanced Oxidation Processes and Reverse Osmosis Treatment of Pharmaceutical in a Municipal
Wastewater Treatment Plant
Patrick Phillips, USGS and Darcy Sachs, O’Brien & Gere
Session 7 – Waste Management & Product Stewardship
Green Chemistry, Drug Therapy, and Design for Degradation Innovations to Reduce the Quantity of
Drugs Entering the Environment
Richard Williams, Environmental Science & Green Chemistry Consulting, LLC
Product Stewardship and Pharmaceuticals
Sierra Fletcher, Product Stewardship Institute
Unwanted Medicines and Educating our Communities: Experiences from the Great Lake States
Shelley Cabrera and Laura Kammin, Illinois – Indiana Sea Grant
Pharmaceutical Stewardship: Proper Disposal of Unwanted or Expired Medications with a Focus on the
Aging Population
Marjorie Copeland, U.S. EPA Headquarters
For more information contact Jaclyn Harrison at 978-349-2507 or via email at jharrison@neiwpcc.org.
